FTTNX
Price
$12.91
Change
+$0.01 (+0.08%)
Updated
Dec 26 closing price
Net Assets
2.07B
HBLRX
Price
$14.83
Change
+$0.01 (+0.07%)
Updated
Dec 26 closing price
Net Assets
11.68B
Interact to see
Advertisement

FTTNX vs HBLRX

Header iconFTTNX vs HBLRX Comparison
Open Charts FTTNX vs HBLRXBanner chart's image
Fidelity Advisor Asset Manager 30% M
Price$12.91
Change+$0.01 (+0.08%)
VolumeN/A
Net Assets2.07B
Hartford Balanced Income R3
Price$14.83
Change+$0.01 (+0.07%)
VolumeN/A
Net Assets11.68B
FTTNX vs HBLRX Comparison Chart in %
View a ticker or compare two or three
VS
FTTNX vs. HBLRX commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTTNX is a StrongBuy and HBLRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HBLRX has more cash in the bank: 11.7B vs. FTTNX (2.07B). HBLRX pays higher dividends than FTTNX: HBLRX (2.85) vs FTTNX (2.36). FTTNX was incepted earlier than HBLRX: FTTNX (18 years) vs HBLRX (16 years). HBLRX (1.28) is less costly to investors than FTTNX (1.05). HBLRX is a more actively managed with annual turnover of: 61.00 vs. FTTNX (19.00). FTTNX (0) and HBLRX (0) have matching initial minimum investment requirements. FTTNX annual gain was more profitable for investors over the last year : 10.32 vs. HBLRX (5.98). FTTNX return over 5 years is better than : 14.37 vs. HBLRX (7.97).
FTTNXHBLRXFTTNX / HBLRX
Total Expense Ratio1.021.2880%
Annual Report Gross Expense Ratio1.051.2882%
Fund Existence18 years16 years-
Gain YTD11.0386.346174%
Front Load4%N/A-
Min. Initial Investment00-
Min. Initial Investment IRA500N/A-
Net Assets2.07B11.7B18%
Annual Yield % from dividends2.362.8583%
Returns for 1 year10.325.98172%
Returns for 3 years25.1116.48152%
Returns for 5 years14.377.97180%
Returns for 10 years45.6040.60112%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RBGLY16.220.04
+0.25%
Reckitt Benckiser Group Plc.
ALYAF1.22N/A
N/A
Alithya Group Inc.
LYPHF0.39N/A
N/A
Luye Pharma Group LTD.
DVHGF0.07N/A
N/A
Devonian Health Group Inc.
BTDPY10.21-0.06
-0.54%
BARRATT REDROW PLC